Contribution of Posterior Corneal Astigmatism to Total Corneal Astigmatism in a Sample of Egyptian Population

May 18, 2020 updated by: Alaa Mohamed Badawy, Cairo University

The Contribution of Posterior Corneal Astigmatism to Total Corneal Astigmatism Using Scheimpflug Analyzer (Pentacam ) in a Sample of Egyptian Population

The magnitude of posterior corneal astigmatism was considered negligible due to the smaller difference in the refractive index between the cornea and the aqueous .

though ,neglecting the posterior corneal astigmatism lead to errors during calculation of the toric iols (over or under estimation ) .

so we aim to determine the percentage of contribution of posterior corneal astigmatism to total corneal astigmatism in a sample of Egyptian population using scheimpflug imaging (Pentacam ).

Study Overview

Status

Unknown

Conditions

Detailed Description

Astigmatism is a common vision condition that causes blurred vision. Astigmatism is an error of refraction in which incident parallel rays can't be focused to a single point .It could be corneal or lenticular astigmatism or both . Regarding Corneal astigmatism it is due to difference in the corneal curvature in the different meridian of both the anterior and posterior surface .

The are 2 methods of studing corneal curvature :

  • Corneal topography which depend on placcido disc to study anterior corneal surface .
  • Corneal tomography is more precise in detecting anterior and posterior corneal curvature depending on Scheimpflug principle which uses a rotating Scheimpflug camera .

Pentacam is a device which depend on Scheimpflug technique .

The importance of studing the posterior corneal curvature includes :

• The posterior corneal curvature is a more sensitive indicator of early keratoconus detection especially posterior corneal elevation.

Previously, The change in the posterior corneal surface plays a more subtle role than the anterior corneal surface in optical performance because of the smaller difference in refractive indices between the cornea and aqueous, and it has been thought that the magnitude of PCA in the normal population is clinically negligible.

Posterior corneal astigmatism (PCA) is important for better predictability of toric intraocular lens calculation to avoid under- or overestimation of toricity in intraocular lens (IOL) power calculations.

But recently it has been demonstrated how neglecting PCA will lead to overcorrection of astigmatism in eyes with with-the-rule astigmatism (WTR) and undercorrection in eyes with against-the-rule astigmatism (ATR).(3) In our study we aim to Determine the contribution of posterior corneal astigmatism to total corneal astigmatism and the error in estimating total corneal astigmatism from anterior corneal measurements only using Scheimpflug analyzer (Pentacam ).

Our patients will undergo Scheimpflug imaging using pentacam .

From the corneal parameters displayed in pentacam we can calculate :

  • Anterior corneal astigmatism by substracting Ksteep -Kflat on the front surface
  • Posterior corneal astigmatism by substracting Ksteep-Kflat on the back surface.
  • Total corneal astigmatism is calculated by addition of anterior and posterior corneal astigmatism using vector analysis by using ASSORT vector calculator.*
  • The percentage of contribution of posterior corneal astigmatism to magnitude of Total corneal astigmatism is then calculated .

ASSORT vector calculator:

Is a total planning and outcomes analysis software for astigmatism using Alpins method ,cheltman ,Victoria ,Australia .

Study Type

Observational

Enrollment (Anticipated)

356

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

candidates presenting for refractive surgery .

Description

Inclusion Criteria:

  1. Patients with corneal astigmatism(±0.5D up tp ±4 D )
  2. Age (18-45 years )
  3. Refractive error (myopia up to -8D)
  4. Hyperopia up to +4
  5. Patients who have clear cornea .
  6. Good quality Scheimpflug analyzer scans.

Exclusion Criteria:

  1. Patients who have any corneal opacity .
  2. Patients who underwent any Previous corneal surgery .
  3. Patients who have Co existing corneal pathology.
  4. Glaucomatus patients.
  5. Patients with any Concomitant ocular disease .
  6. Patients with History of previous ocular trauma .

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
contribution of posterior corneal astigmatism to magnitude of total corneal astigmatism
Time Frame: 3 months
to detect the contribution of posterior corneal astigmatism to total corneal astigmatism to avoid errors during calculation of toric Intra ocular lenses
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2020

Primary Completion (Anticipated)

July 15, 2020

Study Completion (Anticipated)

August 15, 2020

Study Registration Dates

First Submitted

May 14, 2020

First Submitted That Met QC Criteria

May 18, 2020

First Posted (Actual)

May 19, 2020

Study Record Updates

Last Update Posted (Actual)

May 19, 2020

Last Update Submitted That Met QC Criteria

May 18, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Ms-184-2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

we would share our protocol and results through publishing our research

IPD Sharing Time Frame

the data would be available within 3 months and would be available for 6 months

IPD Sharing Supporting Information Type

  • Study Protocol

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Corneal Astigmatism

Clinical Trials on scheimpflug imaging using pentacam

3
Subscribe